Unda 13
Unda 13 is an FDA drug label for the active ingredient BOLDO LEAF, RICINUS COMMUNIS SEED, COMBRETUM RAIMBAULTII LEAF, JATEORHIZA PALMATA ROOT, ARGENTUM METALLICUM manufactured by Seroyal USA administered by ORAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20221108.
Generic: BOLDO LEAF, RICINUS COMMUNIS SEED, COMBRETUM RAIMBAULTII LEAF, JATEORHIZA PALMATA ROOT, ARGENTUM METALLICUM
Manufacturer: Seroyal USA
Product Type: HUMAN OTC DRUG
Route: ORAL
Dosage Form:
NDC: 62106-1112
Application:
Effective: 20221108
Active Ingredients: Active ingredients Each drop contains: Argentum metallicum (Silver) 12X Boldo Leaf 4X Combretum raimbaultii Leaf 4X Jateorhiza palmata (Columbo) Root 4X Ricinus communis (Castor bean) Seed 4X
Indications & Usage
Uses For the temporary relief of symptoms associated with digestive upset. Directions Adults and adolescents (12 years and older) Take 5 drops three times daily or as recommended by your healthcare practitioner. Children (under 12 years) Take under the direction of your healthcare practitioner.
Dosage & Administration
Directions Adults and adolescents (12 years and older) Take 5 drops three times daily or as recommended by your healthcare practitioner. Children (under 12 years) Take under the direction of your healthcare practitioner.
Contraindications
Not available.
Warnings
Warnings Stop use and ask a doctor if symptoms persist or worsen. If pregnant or breastfeeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Adverse Reactions
Not available.
More from same ingredient
No related products.